Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ISA-104 by ISA Pharmaceuticals for Hepatitis B: Likelihood of Approval
ISA-104 is under clinical development by ISA Pharmaceuticals and currently in Phase II for Hepatitis B. According to GlobalData, Phase...